Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The impact of COVID-19 on autologous stem cell transplantation in multiple myeloma: A single-centre, qualitative evaluation study.
Camilleri M, Bekris G, Sidhu G, Buck C, Elsden E, McCourt O, Horder J, Newrick F, Lecat C, Sive J, Papanikolaou X, Popat R, Lee L, Xu K, Kyriakou C, Rabin N, Yong K, Fisher A. Camilleri M, et al. Among authors: horder j. Support Care Cancer. 2022 Sep;30(9):7469-7479. doi: 10.1007/s00520-022-07173-5. Epub 2022 Jun 3. Support Care Cancer. 2022. PMID: 35657402 Free PMC article.
DT-PACE/ESHAP chemotherapy regimens as salvage therapy for multiple myeloma prior to autologous stem cell transplantation.
Ainley L, Chavda SJ, Counsell N, Cheesman S, Newrick F, Horder J, Kyriakou C, Papanikolaou X, Sive J, Lee L, Wechalekar A, Mehta A, Popat R, Rabin N, Yong K. Ainley L, et al. Among authors: horder j. Br J Haematol. 2021 Feb;192(3):e73-e77. doi: 10.1111/bjh.17248. Epub 2020 Nov 25. Br J Haematol. 2021. PMID: 33236352 Free article. No abstract available.
Salvage second autologous stem cell transplant for relapsed multiple myeloma in the novel agent era benefits a subset of patients: single-center UK experience.
Richards H, Chavda SJ, Wilson W, Camilleri M, Cohen O, Horder J, Newrick F, Papanikolaou X, Sive J, Lee L, Popat R, Wechalekar A, Kyriakou C, Yong K, Rabin N. Richards H, et al. Among authors: horder j. Leuk Lymphoma. 2021 Dec;62(14):3544-3547. doi: 10.1080/10428194.2021.1961240. Epub 2021 Aug 4. Leuk Lymphoma. 2021. PMID: 34348069 No abstract available.
Impact of timing of stem cell return following high dose melphalan in multiple myeloma patients with renal impairment: a single center experience.
Nesr G, Shah R, Kyriakou C, Sive J, Popat R, Yong K, Wisniowski B, Xu K, Wechalekar A, Lee L, Ings S, Papanikolaou X, Mahmood S, Mcmillan A, Horder J, Newrick F, Marfil J, Ainley L, Asher S, Cheesman S, Rabin N. Nesr G, et al. Among authors: horder j. Leuk Lymphoma. 2023 Jul-Aug;64(8):1465-1471. doi: 10.1080/10428194.2023.2216817. Epub 2023 Jun 1. Leuk Lymphoma. 2023. PMID: 37259553
Haematopoietic stem cell mobilisation followed by high-dose chemotherapy and autologous stem cell transplantation for patients with sickle cell disease and myeloma.
Asher S, Shah R, Ings S, Horder J, Newrick F, Nesr G, Kesse Adu R, Streetly M, Trompeter S, Lee L, Wisniowski B, Mahmood S, Xu K, Papanikalaou X, McMillan A, Popat R, Yong K, Sive J, Kyriakou C, Rabin N. Asher S, et al. Among authors: horder j. Br J Haematol. 2023 Sep;202(6):1224-1227. doi: 10.1111/bjh.18990. Epub 2023 Jul 24. Br J Haematol. 2023. PMID: 37488061 No abstract available.
Engineering Quantum Light Sources with Flat Optics.
Ma J, Zhang J, Horder J, Sukhorukov AA, Toth M, Neshev DN, Aharonovich I. Ma J, et al. Among authors: horder j. Adv Mater. 2024 Jun;36(23):e2313589. doi: 10.1002/adma.202313589. Epub 2024 Apr 17. Adv Mater. 2024. PMID: 38477536 Review.
130 results